ADAM10 and hepatocellular carcinoma: The authors demonstrated that exosomal miR-451 slowed EMT progression and reduced proliferation, migration and resistance to paclitaxel by suppressing ADAM10 in HCC cells, thus acting as a chemosensitivity-inducing factor and promoting HCC cell apoptosis (85).